Balanced news tone
News Sentiment
2637 sentiment intelligence
Fujian Haixi Pharmaceuticals Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
88/100 classification confidence.
directly relevant articles
high-authority source matches
+3.0% over one week, +16.2% over four weeks, trend active, and near fair-value range.
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 11:16
- Source
- TipRanks
Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 11:16
- Source
- TipRanks
Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 11:16
- Source
- TipRanks
Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 10:46
- Source
- TipRanks
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 09:25
- Source
- TipRanks
Deloitte China assists listing of Haixi Pharma on SEHK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Oct 2025 07:00
- Source
- Deloitte
FUJIAN HAIXI PHARMACEUTICALS CO., LTD. - H SHARES (2637) - stock price, quote, history
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Oct 2025 07:00
- Source
- hkex.com.hk